Medidata vs QuantHealth (2026)
One of these decides what trial to run and the other runs it. QuantHealth simulates outcomes before the protocol is locked, testing thousands of variations against modelled patient populations, which targets the most expensive failure in drug development: a study that could never have worked, discovered three years and a great deal of money later. Medidata's capabilities sit on the platform that holds the trial once it exists, spanning tens of thousands of studies with the most complete security disclosure in this index. They are sequential purchases and a large sponsor will have both. The question for QuantHealth is validation of the simulation itself, comparing modelled outcomes against trials that subsequently ran, because a simulation that makes a marginal protocol look viable is worse than no simulation.
- Its capabilities sit on a clinical trial platform spanning tens of thousands of studies and millions of patients, with the most complete security disclosure in this index.
- For a sponsor already running the platform, capability arrives inside an environment that is already validated.
- Breadth across the lifecycle from study start through regulatory submission covers more than one phase of the work.
- It simulates trial outcomes before the trial runs, letting a team test thousands of protocol variations against modelled populations.
- Simulation targets the most expensive failure in drug development, a protocol that could never have worked, while the design is still cheap to change.
- For a sponsor deciding between arms, endpoints and inclusion criteria, the modelling is aimed at the decision rather than the execution.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Medidata and QuantHealth are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Medidata | QuantHealth |
|---|---|---|
| Primary category | Clinical Trials AI | Clinical Trials AI |
| Founded | Not recorded | 2020 |
| Headquarters | New York, New York | Tel Aviv, Israel |
| Website | medidata.com | quanthealth.ai |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Medidata its top capability grade on several axes, including Security Certifications and Trust Center, FDA and Regulatory Status and EHR and Interoperability Depth. Set against QuantHealth, Medidata grades higher on several axes, including Model Supply Chain Disclosure, Clinical and Operational Evidence and AI Safety and PHI Stewardship. Its thinnest published disclosure sits on AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards QuantHealth its top capability grade on AI Centrality. Set against Medidata, QuantHealth grades higher on AI Centrality, Autonomy and Oversight Model and AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Medidata or QuantHealth?
On the axes where the AI Health Index separates them, Medidata grades higher on several axes, including Model Supply Chain Disclosure, Clinical and Operational Evidence and AI Safety and PHI Stewardship, and QuantHealth grades higher on AI Centrality, Autonomy and Oversight Model and AI Liability and Recourse. Medidata leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Medidata and QuantHealth differ most?
The widest separation the AI Health Index records between Medidata and QuantHealth is on Security Certifications and Trust Center, where Medidata grades A and QuantHealth grades C. That axis sits in the Regulatory and Compliance group, so it should carry the most weight for a buyer whose binding constraint is where regulatory exposure sits and who carries it.
Where do Medidata and QuantHealth grade the same?
The AI Health Index grades Medidata and QuantHealth the same on Model and Technology Transparency, AI Governance and Bias Disclosure and Commercial Transparency. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Medidata and QuantHealth not disclosed?
At the last review, at least one of Medidata and QuantHealth published thin or absent detail on AI Liability and Recourse. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Trials AI page.
These are sequential rather than competing, one before the protocol is locked and the other after. Simulation carries an exposure worth naming: a modelled outcome is only as good as the populations and assumptions behind it, and a simulation that makes a marginal protocol look viable is worse than none, so ask what validation exists comparing simulated outcomes to trials that subsequently ran.
Medidata's AI capabilities are named rather than described and carry no published oversight design. Neither publishes pricing, and both should be asked whether one sponsor's data informs models serving another.